Table III. Enrichment results from a pan-cancer survival analysis.
Cancer type | Number of enriched pathways, upregulated | Number of enriched pathways after set cover, upregulated | Number of enriched pathways, downregulated | Number of enriched pathways after set cover, downregulated |
---|---|---|---|---|
Bladder | 45 | 43 | 7 | 7 |
Breast | 0 | 0 | 16 | 16 |
Colorectal | 0 | 0 | 22 | 20 |
Kidney | 15 | 14 | 11 | 11 |
Leukemia | 29 | 24 | 0 | 0 |
Lung | 39 | 34 | 1 | 1 |
Endometrial | 1 | 1 | 5 | 5 |